Inhibin/activin expression in human and rodent liver: Subunits α and Βb as new players in human hepatocellular carcinoma

British Journal of Cancer

Volumn 104, Issue 8, 2011, Pages 1303-1312

  Frost, K ^a   Seir, K ^a   Lackner, A ^a   Grusch, M ^a   Grasl Kraupp, B ^a   Schulte Hermann, R ^a   Rodgarkia Dara, C ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

activin; hepatocellular carcinoma; inhibin; real time PCR

Indexed keywords

ACTIVIN; INHIBIN; PROTEIN SUBUNIT;

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTIVINS; ADULT; AGED; ANIMALS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBINS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RODENTIA;

EID: 79954433151     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.53     Document Type: Article

References (79)

1. Blanquicett C, Johnson MR, Heslin M, Diasio RB (2002) Housekeeping gene variability in normal and carcinomatous colorectal and liver tissues: applications in pharmacogenomic gene expression studies. Anal Biochem 303: 209-214 (Pubitemid 34407587)
2. Burger HG, Fuller PJ, Chu S, Mamers P, Drummond A, Susil B, Neva P, Robertson DM (2001) The inhibins and ovarian cancer. Mol Cell Endocrinol 180: 145-148 (Pubitemid 32645640)
3. Caradec J, Sirab N, Keumeugni C, Moutereau S, Chimingqi M, Matar C, Revaud D, Bah M, Manivet P, Conti M, Loric S (2010) 'Desperate house genes': the dramatic example of hypoxia. Br J Cancer 102: 1037-1043
4. Chabicovsky M, Herkner K, Rossmanith W (2003) Overexpression of activin beta(C) or activin beta(E) in the mouse liver inhibits regenerative deoxyribonucleic acid synthesis of hepatic cells. Endocrinology 144: 3497-3504 (Pubitemid 36904428)
5. Ciris M, Erhan Y, Zekioglu O, Bayramoglu H (2004) Inhibin alpha and beta expression in ovarian stromal tumors and their histological equivalences. Acta Obstet Gynecol Scand 83: 491-496 (Pubitemid 38534771)
6. De Bleser PJ, Niki T, Xu G, Rogiers V, Geerts A (1997) Localization and cellular sources of activins in normal and fibrotic rat liver. Hepatology 26: 905-912 (Pubitemid 27413656)
7. Deli A, Kreidl E, Santifaller S, Trotter B, Seir K, Berger W, Schulte-Hermann R, Rodgarkia-Dara C, Grusch M (2008) Activins and activin antagonists in hepatocellular carcinoma. World J Gastroenterol 14: 1699-1709 (Pubitemid 351493376)
8. Drucker C, Parzefall W, Teufelhofer O, Grusch M, Ellinger A, Schulte-Hermann R, Grasl-Kraupp B (2006) Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis. Carcinogenesis 27: 152-161 (Pubitemid 43025256)
9. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7: 462-503
10. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576 (Pubitemid 46890874)
11. Esch FS, Shimasaki S, Mercado M, Cooksey K, Ling N, Ying S, Ueno N, Guillemin R (1987) Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. Mol Endocrinol 1: 849-855 (Pubitemid 18033654)
12. Esquela AF, Zimmers TA, Koniaris LG, Sitzmann JV, Lee SJ (1997) Transient down-regulation of inhibin-betaC expression following partial hepatectomy. Biochem Biophys Res Commun 235: 553-556 (Pubitemid 27326518)
13. Fang J, Wang SQ, Smiley E, Bonadio J (1997) Genes coding for mouse activin beta C and beta E are closely linked and exhibit a liver-specific expression pattern in adult tissues. Biochem Biophys Res Commun 231: 655-661 (Pubitemid 27217572)
14. Fine SW, Li M (2003) Expression of calretinin and the alpha-subunit of inhibin in granular cell tumors. Am J Clin Pathol 119: 259-264 (Pubitemid 37047882)
15. Fuller PJ, Chu S, Jobling T, Mamers P, Healy DL, Burger HG (1999) Inhibin subunit gene expression in ovarian cancer. Gynecol Oncol 73: 273-279 (Pubitemid 29215743)
16. Gold EJ, Francis RJ, Zimmermann A, Mellor SL, Cranfield M, Risbridger GP, Groome NP, Wheatley AM, Fleming JS (2003) Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis. Mol Cell Endocrinol 201: 143-153 (Pubitemid 36434290)
17. Gold EJ, O'Bryan MK, Mellor SL, Cranfield M, Risbridger GP, Groome NP, Fleming JS (2004) Cell-specific expression of betaC-activin in the rat reproductive tract, adrenal and liver. Mol Cell Endocrinol 222: 61-69 (Pubitemid 38906658)
18. Gold EJ, Zhang X, Wheatley AM, Mellor SL, Cranfield M, Risbridger GP, Groome NP, Fleming JS (2005) betaA- and betaC-activin, follistatin, activin receptor mRNA and betaC-activin peptide expression during rat liver regeneration. J Mol Endocrinol 34: 505-515 (Pubitemid 40585198)
19. Grasl-Kraupp B, Luebeck G, Wagner A, Low-Baselli A, de Gunst M, Waldhor T, Moolgavkar S, Schulte-Hermann R (2000) Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis). Carcinogenesis 21: 1411-1421 (Pubitemid 30456002)
20. Gray PC, Harrison CA, Vale W (2003) Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci USA 100: 5193-5198 (Pubitemid 36542681)
21. Grusch M, Drucker C, Peter-Vorosmarty B, Erlach N, Lackner A, Losert A, Macheiner D, Schneider WJ, Hermann M, Groome NP, Parzefall W, Berger W, Grasl-Kraupp B, Schulte-Hermann R (2006) Deregulation of the activin/follistatin system in hepatocarcinogenesis. J Hepatol 45: 673-680 (Pubitemid 44466665)
22. Grusch M, Rodgarkia-Dara C, Bursch W, Schulte-Hermann R (2007) Activins and the Liver - Transforming Growth Factor-b in Cancer Therapy, Vol. 1. Humana Press: New York
23. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19
24. Herzer K, Sprinzl MF, Galle PR (2007) Hepatitis viruses: live and let die. Liver Int 27: 293-301 (Pubitemid 46416618)
25. Hofland J, Timmerman MA, de Herder WW, van Schaik RH, de Krijger RR, de Jong FH (2006) Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms. Clin Endocrinol (Oxf) 65: 792-799 (Pubitemid 44772360)
26. Hofland J, van Nederveen FH, Timmerman MA, Korpershoek E, de Herder WW, Lenders JW, Verhofstad AA, de Krijger RR, de Jong FH (2007) Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry. Clin Endocrinol (Oxf) 66: 335-340 (Pubitemid 46239288)
27. Hully JR, Chang L, Schwall RH, Widmer HR, Terrell TG, Gillett NA (1994) Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology 20: 854-862 (Pubitemid 24978376)
28. Iezzoni JC, Mills SE, Pelkey TJ, Stoler MH (1999) Inhibin is not an immunohistochemical marker for hepatocellular carcinoma. An example of the potential pitfall in diagnostic immunohistochemistry caused by endogenous biotin. Am J Clin Pathol 111: 229-234 (Pubitemid 29054951)
29. Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM, Phillips DJ (2007) Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci USA 104: 16239-16244 (Pubitemid 350099391)
30. Kobayashi T, Niimi S, Fukuoka M, Hayakawa T (2002) Regulation of inhibin beta chains and follistatin mRNA levels during rat hepatocyte growth induced by the peroxisome proliferator di-n-butyl phthalate. Biol Pharm Bull 25: 1214-1216 (Pubitemid 39655167)
31. Kobayashi T, Niimi S, Hashimoto O, Hayakawa T (2000) Expression of inhibin betaA, betaB and follistatin mRNAs in the carbon tetrachloride induced rat liver regeneration model. Biol Pharm Bull 23: 755-757 (Pubitemid 30435084)
32. Kogure K, Omata W, Kanzaki M, Zhang YQ, Yasuda H, Mine T, Kojima I (1995) A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology 108: 1136-1142
33. Kogure K, Zhang YQ, Shibata H, Kojima I (1998) Immediate onset of DNA synthesis in remnant rat liver after 90% hepatectomy by an administration of follistatin. J Hepatol 29: 977-984 (Pubitemid 28559068)
34. Lau AL, Kumar TR, Nishimori K, Bonadio J, Matzuk MM (2000) Activin betaC and betaE genes are not essential for mouse liver growth, differentiation, and regeneration. Mol Cell Biol 20: 6127-6137 (Pubitemid 30613060)
35. Lau SK, Prakash S, Geller SA, Alsabeh R (2002) Comparative immuno-histochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol 33: 1175-1181 (Pubitemid 36020066)
36. Laurent-Puig P, Zucman-Rossi J (2006) Genetics of hepatocellular tumors. Oncogene 25: 3778-3786 (Pubitemid 43980473)
37. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W (2000) Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404: 411-414 (Pubitemid 30164345)
38. Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R (1986) Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 321: 779-782 (Pubitemid 16077905)
39. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362: 1907-1917 (Pubitemid 37518510)
40. Macheiner D, Heller G, Kappel S, Bichler C, Stattner S, Ziegler B, Kandioler D, Wrba F, Schulte-Hermann R, Zochbauer-Muller S, Grasl-Kraupp B (2006) NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma. J Hepatol 45: 81-89 (Pubitemid 43850612)
41. Mashima H, Kanzaki M, Nobusawa R, Zhang YQ, Suzuki M, Mine T, Kojima I (1995) Derangements in the activin-follistatin system in hepatoma cells. Gastroenterology 108: 834-840
42. Massague J (2000) How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1: 169-178
43. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H, Bradley A (1994) Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA 91: 8817-8821
44. McCluggage WG, Maxwell P, Patterson A, Sloan JM (1997) Immunohisto-chemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin. Histopathology 30: 518-522 (Pubitemid 27254940)
45. Meunier H, Rivier C, Evans RM, Vale W (1988) Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions. Proc Natl Acad Sci USA 85: 247-251 (Pubitemid 18055325)
46. Niimi S, Horikawa M, Seki T, Ariga T, Kobayashi T, Hayakawa T (2002) Effect of activins AB and B on DNA synthesis stimulated by epidermal growth factor in primary cultured rat hepatocytes. Biol Pharm Bull 25: 437-440 (Pubitemid 40036732)
47. Ohl F, Jung M, Xu C, Stephan C, Rabien A, Burkhardt M, Nitsche A, Kristiansen G, Loening SA, Radonic A, Jung K (2005) Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization? J Mol Med 83: 1014-1024 (Pubitemid 41745760)
48. Pirisi M, Fabris C, Luisi S, Santuz M, Toniutto P, Vitulli D, Federico E, Del Forno M, Mattiuzzo M, Branca B, Petraglia F (2000) Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma. Cancer Detect Prev 24: 150-155 (Pubitemid 30427701)
49. Renshaw AA, Granter SR (1998) A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors. Mod Pathol 11: 1160-1164 (Pubitemid 29009322)
50. Roberts VJ (1997) Tissue-specific expression of inhibin/activin subunit and follistatin mRNAs in mid- to late-gestational age human fetal testis and epididymis. Endocrine 6: 85-90 (Pubitemid 27211802)
51. Rodgarkia-Dara C, Vejda S, Erlach N, Losert A, Bursch W, Berger W, Schulte-Hermann R, Grusch M (2006) The activin axis in liver biology and disease. Mutat Res 613: 123-137 (Pubitemid 44750847)
52. Sagmeister S, Eisenbauer M, Pirker C, Mohr T, Holzmann K, Zwickl H, Bichler C, Kandioler D, Wrba F, Mikulits W, Gerner C, Shehata M, Majdic O, Streubel B, Berger W, Micksche M, Zatloukal K, Schulte-Hermann R, Grasl-Kraupp B (2008) New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis. Br J Cancer 99: 151-159 (Pubitemid 351920238)
53. Salmenkivi K, Arola J, Voutilainen R, Ilvesmaki V, Haglund C, Kahri AI, Heikkila P, Liu J (2001) Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis. J Clin Endocrinol Metab 86: 2231-2235 (Pubitemid 32472945)
54. Schulte-Hermann R, Bursch W, Low-Baselli A, Wagner A, Grasl-Kraupp B (1997) Apoptosis in the liver and its role in hepatocarcinogenesis. Cell Biol Toxicol 13: 339-348 (Pubitemid 27373404)
55. Schwall RH, Robbins K, Jardieu P, Chang L, Lai C, Terrell TG (1993) Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 18: 347-356 (Pubitemid 23225106)
56. Seitz HK, Stickel F (2006) Risk factors and mechanisms of hepatocarcino-genesis with special emphasis on alcohol and oxidative stress. Biol Chem 387: 349-360
57. Sjoholm K, Palming J, Lystig TC, Jennische E, Woodruff TK, Carlsson B, Carlsson LM (2006) The expression of inhibin beta B is high in human adipocytes, reduced by weight loss, and correlates to factors implicated in metabolic disease. Biochem Biophys Res Commun 344: 1308-1314
58. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nat Med 2: 1361-1366
59. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG, Hogenesch JB (2002) Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99: 4465-4470 (Pubitemid 34286008)
60. Takamura K, Tsuchida K, Miyake H, Tashiro S, Sugino H (2005) Activin and activin receptor expression changes in liver regeneration in rat. J Surg Res 126: 3-11 (Pubitemid 40726239)
61. Teicher BA (2001) Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev 20: 133-143 (Pubitemid 34074689)
62. Tricarico C, Pinzani P, Bianchi S, Paglierani M, Distante V, Pazzagli M, Bustin SA, Orlando C (2002) Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem 309: 293-300 (Pubitemid 35387321)
63. Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H (2000) Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J Biol Chem 275: 40788-40796 (Pubitemid 32054898)
64. Tuuri T, Eramaa M, Hilden K, Ritvos O (1994) The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 78: 1521-1524
65. Utoh R, Tateno C, Kataoka M, Tachibana A, Masumoto N, Yamasaki C, Shimada T, Itamoto T, Asahara T, Yoshizato K (2010) Hepatic hyperplasia associated with discordant xenogeneic parenchymal-nonparenchymal interactions in human hepatocyte-repopulated mice. Am J Pathol 177: 654-665
66. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, Spiess J (1986) Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321: 776-779 (Pubitemid 16077904)
67. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034
68. Vejda S, Cranfield M, Peter B, Mellor SL, Groome N, Schulte-Hermann R, Rossmanith W (2002) Expression and dimerization of the rat activin subunits betaC and betaE: evidence for the formation of novel activin dimers. J Mol Endocrinol 28: 137-148 (Pubitemid 34428763)
69. Vejda S, Erlach N, Peter B, Drucker C, Rossmanith W, Pohl J, Schulte-Hermann R, Grusch M (2003) Expression of activins C and E induces apoptosis in human and rat hepatoma cells. Carcinogenesis 24: 1801-1809 (Pubitemid 37408144)
70. Vrettou E, Hytiroglou P, Sikas N, Soultoyannis I, Goodman ZD (2005) Hepatic adenocarcinoma expressing inhibin in a young patient on oral contraceptives. Virchows Arch 446: 560-565 (Pubitemid 40884292)
71. Wada W, Maeshima A, Zhang YQ, Hasegawa Y, Kuwano H, Kojima I (2004) Assessment of the function of the betaC-subunit of activin in cultured hepatocytes. Am J Physiol Endocrinol Metab 287: E247-E254 (Pubitemid 38943889)
72. Wada W, Medina J, Hasegawa Y, Kuwano H, Kojima I (2005) Adenovirus-mediated overexpression of the activin betaC subunit accelerates liver regeneration in partially hepatectomized rats. J Hepatol 43: 823-828 (Pubitemid 41414508)
73. Waxman S, Wurmbach E (2007) De-regulation of common housekeeping genes in hepatocellular carcinoma. BMC Genomics 8: 243
74. Worbs S, Shabani N, Mayr D, Gingelmaier A, Makrigiannakis A, Kuhn C, Jeschke U, Kupka MS, Friese K, Mylonas I (2007) Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers. Oncol Rep 17: 97-104
75. Xu J, McKeehan K, Matsuzaki K, McKeehan WL (1995) Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem 270: 6308-6313
76. Yasuda H, Mine T, Shibata H, Eto Y, Hasegawa Y, Takeuchi T, Asano S, Kojima I (1993) Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 92: 1491-1496 (Pubitemid 23273929)
77. Yuen MF, Norris S, Evans LW, Langley PG, Hughes RD (2002) Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosis. Scand J Gastroenterol 37: 233-238 (Pubitemid 34102262)
78. Zauberman A, Oren M, Zipori D (1997) Involvement of p21(WAF1/Cip1), CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition. Oncogene 15: 1705-1711 (Pubitemid 27466710)
79. Zhang YQ, Shibata H, Schrewe H, Kojima I (1997) Reciprocal expression of mRNA for inhibin betaC and betaA subunits in hepatocytes. Endocr J 44: 759-764 (Pubitemid 28011468)